A Korean premium hyaluronic acid dermal filler built on MDM® (Multi-Dimensional Matrix) Technology for a highly purified, stable, and moldable gel.
STARIS is a Korean premium hyaluronic acid dermal filler developed for facial rejuvenation, wrinkle correction, contour enhancement, and volume restoration. It's marketed as a filler combining characteristics of both monophasic and biphasic gels for smooth injection, structural support, and natural tissue integration, and is exported to multiple international markets including Latin America and the Middle East.
Focuses on complete HA cross-linking, multi-level purification, low residual BDDE, high gel purity, stable viscoelastic properties, strong moldability, and long-lasting correction. According to the manufacturer, this process produces a highly purified gel combining the smoothness of a monophasic filler with the structural support often associated with biphasic fillers.
Fine wrinkles, superficial lines, lip border refinement — mid dermis
Nasolabial folds, marionette lines, moderate folds, lip enhancement — mid-to-deep dermis
Chin, jawline, cheek, deep volume restoration — deep dermis / subcutaneous plane
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
STARIS is marketed internationally through aesthetic distributors and exporters. Manufacturer materials emphasize advanced manufacturing technology and international distribution, but regulatory approval varies by country — patients and practitioners should verify the product is registered with the relevant national health authority before clinical use.
STARIS is positioned as a premium Korean HA dermal filler focused on high gel purity, strong structural support, and natural aesthetic outcomes through its proprietary MDM® Technology. Its three-product lineup — Pisces, Aries, and Taurus — allows treatment from superficial wrinkles through deep volumization. Compared with internationally established brands, STARIS currently has more limited published peer-reviewed clinical evidence, though manufacturer data and early clinical experience highlight favorable handling characteristics, viscosity, and moldability.
